Reviewing the day's trading in various SPDR-ETF markets.

Here are three pharmaceutical ETFs have dropped to support, which means they may be about to rebound.

Stocks have started the second quarter on a strong note, thanks to optimism generated by President Biden’s massive infrastructure plan and the blowout March jobs report.

Cannabis stocks have been the biggest winners to start 2021. Investors seeking to ride the bullish trend could consider these funds.

The government now has the friendliest political environment for the cannabis industry in U.S. history. This has resulted in a spike in cannabis ETFs.